We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




DNA Microarray Detects 18 Important Human Blood Protozoan Species

By LabMedica International staff writers
Posted on 22 Dec 2016
Accurate detection of blood protozoa from clinical samples is important for diagnosis, treatment and control of related diseases and developing a rapid, simple, and convenient detection method for protozoan detection is an urgent need.

Blood protozoa are single-cell organisms that often have flagella, cilia or other structures that help them move. More...
They sometimes form parasitic relationships with humans and cause diseases or infections. The most common blood protozoa in humans, animals, and vectors include Plasmodium, Leishmania, Trypanosoma, Toxoplasma gondii and Babesia.

Scientists at Fudan University (Shanghai, PR China) and their colleagues collected a total of 438 samples from humans, animals and vectors from August 2012 to December 2014 as well as 100 blood samples from healthy individuals. Reference blood protozoan samples were either stored in the laboratory or kindly provided by different partner laboratories. Blood smears were prepared for each clinical blood sample and were examined under an oil immersion lens at a total magnification of ×1000 for presence of blood protozoa.

The whole blood that was suspected infected Leishmania from human and canine was also tested by the Kalazar Detect dipstick, a recombinant k39 antigen-based immunochromatographic strip, to detect anti-leishmanial antibodies (InBios International, Seattle, WA, USA). The team performed microarray assays simultaneously that identified 18 species of common blood protozoa based on the differences in respective target genes. A total of 20 specific primer pairs and 107 microarray probes were selected according to conserved regions, which were designed to identify 18 species in five blood protozoan genera.

The scientists found that the positive detection rate of the microarray assay was 91.8% (402/438). Sensitivity and specificity for blood protozoan detection ranged from 82.4% to 100.0% and 95.1% to 100.0%, respectively. Positive predictive value (PPV) and negative predictive value (NPV) ranged from 20.0% to 100.0% and 96.8% to 100.0%, respectively. Youden index varied from 0.82 to 0.98. The detection limit of the DNA microarrays ranged from 200 to 500 copies/reaction, which was similar to the polymerase chain reaction (PCR) findings. The concordance rate between microarray data and DNA sequencing results was 100%.

The authors concluded that overall, the microarray platform can provide a convenient, accurate and reliable diagnostic tool for the identification of 18 of the most common blood protozoan species. The system should be widely used in future detection assay and management of blood protozoan infections in busy hospitals and research institutes, and would help in disease control and prevention plans. The study was published on December 2, 2016, in the Public Library of Science Neglected Tropical Diseases.

Related Links:
Fudan University
InBios International

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Procalcitonin Test
LIAISON B•R•A•H•M•S PCT II GEN
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.